Safety of intravenously applied mistletoe extract – results from a phase I dose escalation study in patients with advanced cancer

BACKGROUND: Mistletoe extracts have anti-tumor properties and are approved for subcutaneous use in cancer patients. Data on Intravenous application are limited. METHODS: An aqueous extract from pine-mistletoe was used to investigate maximum tolerable dose (MTD) and safety of intravenous application....

Descripción completa

Detalles Bibliográficos
Autores principales: Huber, Roman, Schlodder, Dietrich, Effertz, Carola, Rieger, Sabine, Tröger, Wilfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604151/
https://www.ncbi.nlm.nih.gov/pubmed/28923036
http://dx.doi.org/10.1186/s12906-017-1971-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604151/
https://www.ncbi.nlm.nih.gov/pubmed/28923036
http://dx.doi.org/10.1186/s12906-017-1971-1

Ejemplares similares